Wang; Xiaozhao
Patent Applications and Registrations
Patent applications and USPTO patent grants for Wang; Xiaozhao.The latest application filed is for "imidazole and triazole kras inhibitors".
Company Profile
29.26.50
- Wang; Xiaozhao - Mt. Laurel NJ
- Wang; Xiaozhao - Wilmington DE
- Wang; Xiaozhao - Drexel Hill PA
Patent Activity
| Patent | Date |
|---|---|
| Imidazole And Triazole Kras Inhibitors App 20220306633 - Qi; Chao ; et al. | 2022-09-29 |
| Combination Therapy Comprising A2a/a2b Inhibitors, Pd-1/pd-l1 Inhibitors, And Anti-cd73 Antibodies App 20220233529 - Wang; Hui ; et al. | 2022-07-28 |
| Pyrazolopyridines and triazolopyridines as A2A / A2B inhibitors Grant 11,390,624 - Huang , et al. July 19, 2 | 2022-07-19 |
| Pyrrole Tricyclic Compounds As A2a / A2b Inhibitors App 20220213112 - Wang; Xiaozhao ; et al. | 2022-07-07 |
| Fused Pyrazine Derivatives As A2a / A2b Inhibitors App 20220135570 - Wang; Xiaozhao ; et al. | 2022-05-05 |
| Bicyclic Dione Compounds As Inhibitors Of Kras App 20220106309 - Huang; Taisheng ; et al. | 2022-04-07 |
| Vinyl Imidazole Compounds As Inhibitors Of Kras App 20220064188 - Carlsen; Peter ; et al. | 2022-03-03 |
| Cyclopropylamines as LSD1 inhibitors Grant 11,247,992 - Wu , et al. February 15, 2 | 2022-02-15 |
| Pyrrole tricyclic compounds as A2A / A2B inhibitors Grant 11,220,510 - Wang , et al. January 11, 2 | 2022-01-11 |
| Fused Pyrimidine Compounds As Kras Inhibitors App 20210355141 - Hoang; Gia ; et al. | 2021-11-18 |
| Fused Tricyclic Kras Inhibitors App 20210355121 - ZHU; Wenyu ; et al. | 2021-11-18 |
| Fused pyrimidine derivatives as A2A / A2B inhibitors Grant 11,168,089 - Wang , et al. November 9, 2 | 2021-11-09 |
| Fused pyrazine derivatives as A2A / A2B inhibitors Grant 11,161,850 - Wang , et al. November 2, 2 | 2021-11-02 |
| Pyrrolopyrimidine derivatives as TAM inhibitors Grant 11,136,326 - Li , et al. October 5, 2 | 2021-10-05 |
| Tricyclic Compounds As Inhibitors Of Kras App 20210269434 - Wang; Xiaozhao ; et al. | 2021-09-02 |
| Fused Pyrimidine Derivatives As A2a / A2b Inhibitors App 20210261555 - Wang; Xiaozhao ; et al. | 2021-08-26 |
| Cd73 Inhibitor And A2a/a2b Adenosine Receptor Inhibitor Combination Therapy App 20210230294 - Nastri; Horacio G. ; et al. | 2021-07-29 |
| Spiro Compounds As Inhibitors Of Kras App 20210230162 - Zhao; Le ; et al. | 2021-07-29 |
| Combination Therapy Comprising A2A/A2B and PD-1/PD-L1 Inhibitors App 20210205311 - Wang; Hui ; et al. | 2021-07-08 |
| Pyrrolotriazine Compounds As Tam Inhibitors App 20210147430 - Li; Yun-Long ; et al. | 2021-05-20 |
| Imidazopyrimidines And Triazolopyrimidines As A2a / A2b Inhibitors App 20210139485 - Wang; Xiaozhao ; et al. | 2021-05-13 |
| Substituted [1,2,4]triazolo[1,5-a]pyrazines as LSD1 inhibitors Grant 10,968,221 - Wu , et al. April 6, 2 | 2021-04-06 |
| Triazolopyrimidines As A2a / A2b Inhibitors App 20210061809 - Han; Heeoon ; et al. | 2021-03-04 |
| Cyclopropylamines As Lsd1 Inhibitors App 20210032244 - Wu; Liangxing ; et al. | 2021-02-04 |
| Pyrrolotriazine compounds as TAM inhibitors Grant 10,844,069 - Li , et al. November 24, 2 | 2020-11-24 |
| Bicyclic Heterocycles As Fgfr4 Inhibitors App 20200306256 - Lu; Liang ; et al. | 2020-10-01 |
| Pyrazolopyridines And Triazolopyridines As A2a / A2b Inhibitors App 20200270244 - Huang; Taisheng ; et al. | 2020-08-27 |
| Heterocyclic compounds and uses thereof Grant 10,723,705 - Pan , et al. | 2020-07-28 |
| Pyrrolopyrimidine Derivatives As Tam Inhibitors App 20200181151 - Li; Yun-Long ; et al. | 2020-06-11 |
| Pyrrolotriazine Compounds As Tam Inhibitors App 20200131185 - Li; Yun-Long ; et al. | 2020-04-30 |
| Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors Grant 10,556,908 - Wu , et al. Feb | 2020-02-11 |
| Fused Pyrazine Derivatives As A2a / A2b Inhibitors App 20200031835 - Wang; Xiaozhao ; et al. | 2020-01-30 |
| Triazolopyridines And Triazolopyrazines As Lsd1 Inhibitors App 20200024277 - Wu; Liangxing ; et al. | 2020-01-23 |
| Pyrrolopyrimidine derivatives as TAM inhibitors Grant 10,519,163 - Li , et al. Dec | 2019-12-31 |
| Fused Pyrimidine Derivatives As A2a / A2b Inhibitors App 20190375752 - Wang; Xiaozhao ; et al. | 2019-12-12 |
| Pyrrole Tricyclic Compounds As A2a / A2b Inhibitors App 20190337957 - Wang; Xiaozhao ; et al. | 2019-11-07 |
| Pyrrolotriazine compounds as TAM inhibitors Grant 10,442,810 - Li , et al. Oc | 2019-10-15 |
| Imidazopyrimidines And Triazolopyrimidines As A2a / A2b Inhibitors App 20190292188 - Wang; Xiaozhao ; et al. | 2019-09-26 |
| Bicyclic Heterocycles As Fgfr4 Inhibitors App 20190269693 - Lu; Liang ; et al. | 2019-09-05 |
| Cyclopropylamines As Lsd1 Inhibitors App 20190211014 - Wu; Liangxing ; et al. | 2019-07-11 |
| Cyclopropylamines as LSD1 inhibitors Grant 10,300,051 - Wu , et al. | 2019-05-28 |
| Triazolopyridines And Triazolopyrazines As Lsd1 Inhibitors App 20190152976 - Wu; Liangxing ; et al. | 2019-05-23 |
| Triazolopyridines And Triazolopyrazines As Lsd1 Inhibitors App 20190119272 - Wu; Liangxing ; et al. | 2019-04-25 |
| Imidazopyrazines As Lsd1 Inhibitors App 20190106426 - Wu; Liangxing ; et al. | 2019-04-11 |
| Pyrrolopyrimidine Derivatives As Tam Inhibitors App 20190031663 - Li; Yun-Long ; et al. | 2019-01-31 |
| Cyclopropylamines as LSD1 inhibitors Grant 10,174,030 - Wu , et al. J | 2019-01-08 |
| Triazolopyridines and triazolopyrazines as LSD1 inhibitors Grant 10,138,249 - Wu , et al. Nov | 2018-11-27 |
| Pyrrolotriazine Compounds As Tam Inhibitors App 20180327412 - Li; Yun-Long ; et al. | 2018-11-15 |
| Substituted [1,2,4]triazolo[1,5-a]pyridines and substituted [1,2,4]triazolo[1,5-a]pyrazines as LSD1 inhibitors Grant 10,125,133 - Wu , et al. November 13, 2 | 2018-11-13 |
| Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors Grant 10,112,950 - Wu , et al. October 30, 2 | 2018-10-30 |
| Heterocyclic Compounds And Uses Thereof App 20180244627 - Pan; Jun ; et al. | 2018-08-30 |
| Pyrrolopyrimidine derivatives as TAM inhibitors Grant 10,053,465 - Li , et al. August 21, 2 | 2018-08-21 |
| Pyrrolotriazine compounds as tam inhibitors Grant 9,981,975 - Li , et al. May 29, 2 | 2018-05-29 |
| Imidazopyrazines As Lsd1 Inhibitors App 20170369497 - Wu; Liangxing ; et al. | 2017-12-28 |
| Triazolopyridines And Triazolopyrazines As Lsd1 Inhibitors App 20170369488 - Wu; Liangxing ; et al. | 2017-12-28 |
| Triazolopyridines And Triazolopyrazines As Lsd1 Inhibitors App 20170362245 - Wu; Liangxing ; et al. | 2017-12-21 |
| Cyclopropylamines As Lsd1 Inhibitors App 20170342070 - Wu; Liangxing ; et al. | 2017-11-30 |
| Bicyclic Heterocycles As Fgfr4 Inhibitors App 20170290839 - Lu; Liang ; et al. | 2017-10-12 |
| Pyrrolotriazine Compounds As Tam Inhibitors App 20170275290 - Li; Yun-Long ; et al. | 2017-09-28 |
| Triazolopyridines and triazolopyrazines as LSD1 inhibitors Grant 9,758,523 - Wu , et al. September 12, 2 | 2017-09-12 |
| Bicyclic heterocycles as FGFR4 inhibitors Grant 9,708,318 - Lu , et al. July 18, 2 | 2017-07-18 |
| Substituted triazolo[1,5-a]pyridines and triazolo[1,5-a]pyrazines as LSD1 inhibitors Grant 9,695,167 - Wu , et al. July 4, 2 | 2017-07-04 |
| Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors Grant 9,695,180 - Wu , et al. July 4, 2 | 2017-07-04 |
| Cycloalkyl-dione derivatives and methods of their use Grant 9,643,919 - Ballatore , et al. May 9, 2 | 2017-05-09 |
| Cyclopropylamines As Lsd1 Inhibitors App 20170112816 - Wu; Liangxing ; et al. | 2017-04-27 |
| Pyrrolopyrimidine Derivatives As Tam Inhibitors App 20170057965 - Li; Yun-Long ; et al. | 2017-03-02 |
| Cyclopropylamines as LSD1 inhibitors Grant 9,493,442 - Wu , et al. November 15, 2 | 2016-11-15 |
| Bicyclic Heterocycles As Fgfr4 Inhibitors App 20160244449 - Lu; Liang ; et al. | 2016-08-25 |
| Cycloalkyl-dione Derivatives And Methods Of Their Use App 20160031805 - BALLATORE; Carlo ; et al. | 2016-02-04 |
| Imidazopyrazines As Lsd1 Inhibitors App 20160009720 - Wu; Liangxing ; et al. | 2016-01-14 |
| Triazolopyridines And Triazolopyrazines As Lsd1 Inhibitors App 20160009721 - Wu; Liangxing ; et al. | 2016-01-14 |
| Triazolopyridines And Triazolopyrazines As Lsd1 Inhibitors App 20160009711 - Wu; Liangxing ; et al. | 2016-01-14 |
| Cyclopropylamines As Lsd1 Inhibitors App 20150225379 - Wu; Liangxing ; et al. | 2015-08-13 |
| Cyclopropylamines As Lsd1 Inhibitors App 20150225401 - Wu; Liangxing ; et al. | 2015-08-13 |
| Thromboxane A2 (TP) receptor antagonists Grant 8,927,586 - Trojanowski , et al. January 6, 2 | 2015-01-06 |
| Novel Thromboxane A2 (TP) Receptor Antagonists App 20130165488 - Trojanowski; John Q. ; et al. | 2013-06-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 